Related by context. All words. (Click for frequent words.) 78 refractory chronic lymphocytic 77 PNP inhibitor 76 Orally administered 76 vapreotide acetate 76 liposomal formulation 76 oral prodrug 75 Panzem R NCD 75 nitric oxide donating prostaglandin 75 intranasal formulation 74 pharmacologically active isomer 74 TNF Tumor Necrosis Factor 74 Personalized Immunotherapy 74 Annamycin 74 non nucleoside inhibitor 74 TBC# 74 PEGylated Fab fragment 74 PEGylated interferon 73 cetuximab Erbitux R 73 ospemifene 73 docetaxel Taxotere ® 73 polymerase inhibitor 73 Lenalidomide 73 Voreloxin 73 receptor tyrosine kinase inhibitor 73 PDE4 inhibitor 73 PEGylated anti 73 gemcitabine Gemzar ® 73 dasatinib Sprycel ® 73 forodesine 73 IL# PE#QQR 73 subcutaneous formulation 73 targeted radiotherapeutic 73 TELINTRA 73 TELINTRA R 73 metastatic malignant 73 octreotide implant 73 mTOR inhibitor 73 luteinizing hormone releasing 73 Kamada AAT 73 Mipomersen 73 Archexin 72 Tarceva TM 72 Vidaza azacitidine 72 corticosteroid dexamethasone 72 volociximab 72 Clolar ® 72 novel VDA molecule 72 TLK# 72 Ixabepilone 72 CYT# potent vascular disrupting 72 Plicera 72 LymphoStat B TM 72 Angiotensin Converting Enzyme 72 Tasimelteon 72 SPRYCEL ® 72 Initiate Phase 72 Temsirolimus 72 LymphoStat B belimumab 72 Xanafide 72 vidofludimus 72 methylnaltrexone bromide 72 FOLOTYN ® 72 orally inhaled 72 Degarelix 72 dasatinib Sprycel 72 Dasatinib 72 BCR ABL inhibitor 72 Cimzia TM 72 selective modulator 72 BENLYSTA ® 72 lucinactant 72 antibody MAb 72 diarrhea predominant irritable 72 novel emulsion formulation 72 Evoltra ® 71 hormone LHRH antagonist 71 Panzem R 71 MAGE A3 ASCI 71 vinorelbine tartrate 71 pan HDAC inhibitor 71 Clevudine 71 nucleoside analog 71 TO AVOID PREGNANCY WHILE 71 5 HT3 antagonist 71 Pimavanserin 71 GW# [003] 71 beta 1a 71 Investigational Oral 71 Safinamide 71 Vidaza R 71 subcutaneously administered 71 Apoptone 71 immunomodulatory therapy 71 Elagolix 71 novel histone deacetylase 71 non nucleoside 71 erlotinib Tarceva ® 71 Phase #b/#a clinical 71 Zorbtive TM 71 Azacitidine 71 ® lenalidomide 71 dihydrochloride 71 Preclinical studies suggest 71 adenosine injection 71 Denufosol 71 thetreatment 71 Tezampanel 71 Meets Primary Endpoint 71 Luteinizing Hormone Releasing Hormone 71 radiation sensitizer 71 thalidomide Thalomid 71 histamine dihydrochloride 71 EGFR TKI 71 denileukin diftitox 71 oral ridaforolimus 71 biomodulator 71 cutaneous T 71 orally administered inhibitor 71 metaglidasen 71 developing Bicifadine serotonin 71 pan histone deacetylase 71 acyclovir Lauriad R 71 Peginterferon alfa 2b 71 selective antagonist 71 refractory acute myeloid 71 2 methoxyestradiol 71 orally bioavailable 71 Phase IIb clinical trials 71 Silodosin 71 phase IIb clinical 71 CTAP# Capsules 71 GLP1 71 Interferon beta 1a 71 alkylating agent 71 anticancer compound 71 FDA APPROVES 71 paclitaxel Taxol ® 71 Tesamorelin 71 2A receptor agonist 71 RH1 71 cetuximab Erbitux ® 71 AAG geldanamycin analog 71 IAP inhibitor 71 Panzem NCD 71 IMiDs ® 70 YONDELIS 70 mGluR5 negative 70 Daclizumab 70 somatostatin analogue 70 Spiegelmer ® 70 sapropterin dihydrochloride 70 induced macular edema 70 bevacizumab Avastin R 70 RhuDex ® 70 Cloretazine ® 70 Sanvar R 70 histone deacetylase HDAC inhibitor 70 AKT inhibitor 70 Amrubicin 70 Vicriviroc 70 Initiate Clinical Trial 70 EVIZON TM 70 AEG# 70 multi kinase inhibitor 70 CDK inhibitor 70 Pegloticase 70 monoclonal antibody conjugated 70 Ostabolin C TM 70 clotrimazole 70 paclitaxel poliglumex 70 chronic eosinophilic leukemia 70 inhalation powder 70 inhaled formulation 70 oxymorphone ER 70 PRN FDA Approves 70 Zenvia ™ 70 hypoxia activated prodrug 70 R Saizen R 70 Onalta ™ 70 sitaxsentan 70 orally inhaled migraine 70 docetaxel Taxotere R 70 Hsp# Inhibitor 70 phosphorylase PNP inhibitor 70 registrational trial 70 humanized monoclonal 70 ergot derivatives 70 Bosutinib 70 albiglutide 70 selective phosphodiesterase 70 lanreotide 70 etanercept Enbrel 70 bortezomib Velcade 70 Pyridorin 70 antiangiogenic agent 70 virus HCV protease inhibitor 70 LHRH receptor positive 70 proteasome inhibitor 70 GAMMAGARD 70 Deforolimus 70 interferon gamma 1b 70 ADP receptor antagonist 70 histone deacetylase inhibitor 70 huN# DM1 70 evaluating tivozanib 70 dopamine partial agonist 70 Enzyme Replacement Therapy 70 Factor VIIa 70 Iluvien ® 70 Lispro 70 PEG SN# 70 selective orally bioavailable 70 Pivotal Phase III 70 Pharmacokinetics PK 70 JAK2 inhibitor 70 PN# [001] 70 angiogenesis inhibitor 70 Maribavir 70 Receives Orphan Drug Designation 70 Liposomal 70 Inhalation Powder 70 PEG IFN 70 aldehyde dehydrogenase ALDH2 deficiency 70 Quinamed 70 mertansine 70 immunotherapeutic agent 70 Ropinirole 70 leukemia AML 70 prokinetic agent 70 SYN# 70 alfa 2a 70 topoisomerase II inhibitor 70 Inhalation Aerosol 70 Aflibercept 70 R sorafenib tablets 70 FUSILEV enhances 70 lapatinib Tykerb 70 targeted antifolate 70 IMiDs R 70 Begins Dosing 70 investigational monoclonal antibody 70 sodium glucose cotransporter 70 ara C 70 small molecule thrombopoietin 70 candidate deforolimus 70 Febuxostat 70 Trobalt 70 5 fluorouracil leucovorin 69 Completes Patient Enrollment 69 epothilone 69 Ophena TM 69 paclitaxel Taxol 69 Tyrima 69 Pafuramidine 69 Fodosine 69 FOLFOX6 chemotherapy regimen 69 phase III isavuconazole 69 topically administered 69 Pemetrexed 69 VEGFR2 inhibitor 69 oral rivaroxaban 69 ZOLINZA 69 sorafenib Nexavar 69 treat chronic sinusitis 69 reslizumab 69 Letairis ambrisentan 69 IV Busulfex 69 omacetaxine mepesuccinate 69 xanthine oxidase inhibitor 69 chemosensitizer 69 Pazopanib 69 sorafenib tablets 69 Achieves Primary Endpoint 69 KNS # 69 GTC recombinant human 69 Initiates Phase II 69 norepinephrine reuptake inhibitor 69 systemic anaplastic large 69 JAK3 inhibitor 69 Phase #b/#a trial 69 HGS# 69 Darinaparsin 69 phase IIb trial 69 highly selective inhibitor 69 #mg/#mg 69 pregabalin Lyrica 69 Anti VEGF 69 androgen receptor antagonist 69 Ceflatonin 69 Phase Ib study 69 ALN PCS 69 novel prodrug 69 selective A2A adenosine receptor 69 molecular imaging radiopharmaceutical 69 ruxolitinib 69 Octreotide 69 vinca alkaloid 69 catheter occlusion 69 Romidepsin 69 Mycophenolate Mofetil 69 HuMax CD4 69 HuMax EGFr 69 PrevOnco ™ 69 gefitinib Iressa 69 oral beclomethasone dipropionate 69 platinum chemotherapeutic 69 pain palliation 69 imatinib Gleevec ® 69 Genasense ® oblimersen 69 isoform selective 69 Teysuno 69 lintuzumab SGN 69 visilizumab 69 MOVIPREP R 69 Granulocyte Colony Stimulating Factor 69 ELACYT 69 octreotide acetate 69 CG# [003] 69 hypereosinophilic syndrome 69 Cloretazine 69 Intravitreal 69 Aztreonam 69 alefacept 69 Lixivaptan 69 Anavex #-# 69 Irinotecan 69 administered subcutaneously 69 omega interferon 69 Ecallantide 69 Immunotherapeutic 69 Ozarelix 69 Phase IIb trials 69 including eniluracil ADH 69 estramustine 69 small molecule Hedgehog 69 oral proteasome inhibitor 69 Romiplostim 69 alvespimycin 69 Glatiramer Acetate 69 nucleoside reverse transcriptase inhibitor 69 dextromethorphan quinidine 69 inhibitor PPI 69 selective androgen receptor modulator 69 MGd 69 non porcine pancreatic 69 hyaluronidase enzyme 69 Noxafil 69 Multiple Ascending Dose 69 Vascular Disrupting Agent 69 Omacetaxine 69 itraconazole Sporanox 69 Xeloda ® 69 SinuNase TM 69 evaluating picoplatin 69 PRT# 69 acetonide FA 69 topical gel formulation 69 ritonavir boosted 69 bevacizumab Avastin ® 69 HCV RNA polymerase 69 BrachySil TM 69 mesylate 69 Lamictal ODT 69 Mg Uk 69 Phase IIb Trial 69 Marqibo TM 69 biologic DMARD 69 adalimumab Humira 69 fosbretabulin 69 microtubule inhibitor 69 Fludarabine 69 pentostatin 69 apomorphine hydrochloride 69 XL# XL# 69 XL# anticancer compounds 69 MKC# 69 antibody MT# 69 Hycamtin ® 69 aurora kinase 69 highly selective endothelin 69 leukotriene receptor antagonist 69 vascular disrupting agent 69 PHX# 69 Zybrestat 69 CCR5 antagonist 69 Saquinavir 69 proprietary polysaccharide 69 Gel repository corticotropin injection 69 herpetic keratitis 69 platelet inhibitor 69 Telintra 69 Interferon beta 69 DURIN TM 69 novel oral anticoagulant 69 EOquin TM 69 Vaprisol 68 Decitabine 68 GALNS 68 Phase 2b Clinical Trial 68 MKC# MT 68 ocular formulation 68 OvaRex R 68 Squalamine 68 5 FU leucovorin 68 fumarate 68 Sapacitabine 68 myelodysplastic myeloproliferative diseases 68 Initiates Clinical 68 basal insulin analogue 68 tyrosine kinase inhibitor TKI 68 Simulect 68 tiuxetan 68 oxaliplatin Eloxatin 68 DU #b 68 VEGF inhibitor 68 formoterol fumarate 68 PI3K/Akt pathway inhibitor 68 gonadotropin releasing hormone GnRH 68 RhuDex TM 68 investigational humanized monoclonal antibody 68 Phase 1a clinical 68 Nucleoside 68 5 HT2A serotonin 68 Cetuximab Erbitux 68 SAR# [004] 68 Campath alemtuzumab 68 refractory cutaneous T 68 Ziprasidone 68 Cannabinor 68 miconazole Lauriad ® 68 diabetic neuropathic pain 68 chimeric monoclonal antibody 68 long acting muscarinic 68 Torisel 68 signal transduction inhibitor 68 humanized anti 68 small molecule chemotherapeutic 68 Diabetic Macular Edema DME 68 BEMA Granisetron 68 nasal spray formulation 68 Egrifta 68 Gemzar gemcitabine 68 allosteric modulator NAM 68 triphendiol 68 ALN HPN 68 LHRH antagonist 68 Exendin 4 68 peripherally acting 68 R bisoprolol Euthyrox 68 either acutely decompensated 68 Allovectin 7 68 Dacogen injection 68 investigational antiplatelet agent 68 HSP# inhibitor 68 Lubiprostone 68 Oral Spray 68 hereditary deficiency 68 goserelin 68 Dapagliflozin 68 protein tyrosine phosphatase 1B 68 Gleevec imatinib mesylate 68 Serostim ® 68 Glucagon Like Peptide 68 synthetic peptide containing 68 demethylating agent 68 Altera Nebulizer System 68 PrevOnco 68 cysteamine bitartrate 68 PDX pralatrexate 68 selectively binds 68 baminercept 68 Eltrombopag 68 orally disintegrating tablets 68 Initiates Clinical Trial 68 Roflumilast 68 Corlux 68 paclitaxel Taxol R 68 Mg Usa 68 HCl capsules 68 Levoleucovorin 68 tubulin inhibitor 68 Navelbine ® 68 Topotecan 68 cortisol synthesis 68 riociguat 68 ribavirin RBV 68 inhaled antibiotic 68 non splenectomized 68 FEMALES SHOULD BE ADVISED 68 panitumumab Vectibix R 68 Bortezomib 68 Presents Preclinical 68 calcineurin inhibitor 68 hyperphenylalaninemia HPA due 68 Kuvan sapropterin dihydrochloride 68 CEQ# 68 seliciclib CYC# 68 bazedoxifene selective estrogen receptor 68 Syncria 68 RezularTM 68 HFA MDI 68 pancreatic enzyme replacement 68 adefovir dipivoxil 68 oral nucleoside analogue 68 cell lymphoma CTCL 68 humanised monoclonal antibody 68 chronic thromboembolic pulmonary 68 Civacir 68 pioglitazone HCl 68 Tyrosine Kinase Inhibitor 68 CRMD# 68 radiotherapeutic 68 Genz # 68 small molecule tyrosine 68 R roscovitine 68 Iloperidone 68 polycythemia vera essential thrombocythemia 68 Anidulafungin 68 Adenoscan R 68 Pralatrexate 68 LEP ETU 68 SUTENT ® 68 Epratuzumab 68 ORENCIA ® 68 CYT# QbG# 68 Ceplene TM 68 Fludara ® 68 ceftazidime 68 2 inhibitor CYT# 68 Enkephalin 68 Dacogen decitabine 68 multikinase inhibitor 68 Pramlintide 68 verteporfin 68 EVIZON ™ 68 tolevamer 68 ATPace TM 68 liver resection surgeries 68 prostaglandin E1 68 oropharyngeal candidiasis OPC 68 Glufosfamide 68 PD LID 68 Albuferon TM 68 CYP#A# CYP#D# 68 generation PNP inhibitor 68 Myelodysplastic Syndrome MDS 68 aripiprazole Abilify 68 Golimumab 68 Cleviprex TM clevidipine 68 Interferon alpha 68 oral picoplatin 68 Certolizumab pegol 68 Novel Oral 68 Camptosar ® 68 JAK inhibitor 68 multiple myeloma MM 68 peritumoral brain edema 68 PANVAC VF 68 schizophrenia CIAS 68 Myolimus 68 demonstrated antitumor activity 68 esophageal candidiasis 68 R lenalidomide 68 XYOTAX TM 68 orally dosed 68 Vitrasert R 68 Aclidinium 68 dependent kinase inhibitor 68 rhIGF-I/rhIGFBP-3 68 systemic immunosuppressive drugs 68 tazobactam 68 FUSILEV ® 68 systemically administered 68 Dual Opioid 68 reduce serum phosphate 68 erlotinib Tarceva 68 AFREZZA TM 68 Galantamine 68 ALVESCO R 68 Pruvel TM 68 ZEVALIN ® 68 cromolyn sodium 68 ONTAK 68 Aurora Kinase 68 Ambrisentan 68 oxypurinol 68 Icatibant 68 CDP# 68 HDAC Inhibitor 68 Xyfid TM 68 DNA demethylating agent 68 Pivotal Phase 68 Myocet 68 Insulin PH# 68 prescribed proton pump 68 Darusentan 68 selective estrogen receptor modulator 68 Gamunex C 68 tezampanel NGX# 68 TLR9 agonist 68 ILUVIEN ® 68 gastrointestinal stromal tumors GIST 68 potentially hepatotoxic 68 pharmacokinetic PK study 68 TRIOLEX ™ 68 rALLy clinical trial 68 Frova ® 68 pegylated 68 phase IIb study 67 Soliris eculizumab 67 lexidronam injection 67 intravesical instillation 67 Chemophase 67 Hormone Refractory Prostate Cancer 67 epoetin alpha 67 Acute Myeloid Leukemia AML 67 eniluracil 67 XP# XP# 67 hormone agonist 67 anti angiogenic agent 67 intravenously administered 67 Dose Ranging Study 67 Lodotra TM 67 evaluating satraplatin 67 tiapamil 67 Methylnaltrexone 67 diabetic gastroparesis 67 Fx #A 67 Vandetanib 67 Bezielle 67 OMNARIS HFA 67 Clofarabine 67 rxRNA 67 AVAPRO 67 Sudhir Agrawal D.Phil 67 nilotinib Tasigna ® 67 brand ciclesonide HFA 67 THR beta agonist 67 tumor vascular disrupting 67 MyVax R 67 oral methylnaltrexone 67 KRN# 67 orally disintegrating 67 cetuximab Erbitux 67 mitoxantrone plus 67 essential thrombocythemia ET 67 TAXOTERE R 67 Metformin GR 67 iobenguane 67 administered concomitantly 67 VELCADE melphalan 67 sunitinib Sutent 67 RANK Ligand inhibitor 67 generation antisense inhibitor 67 injectable formulation 67 levoleucovorin 67 Fc fusion protein 67 Gliadel Wafer 67 ribavirin Copegus ® 67 Ofatumumab 67 tenofovir emtricitabine 67 Fingolimod 67 oral salmon calcitonin 67 DURECT proprietary 67 Neuvenge 67 Zenpep 67 Copegus ® 67 advanced metastatic renal 67 weekly subcutaneous injections 67 myelofibrosis polycythemia vera 67 IMA# 67 MNTX 67 NeuroSTAT ® 67 trastuzumab DM1 T DM1 67 mGluR5 NAM 67 5 HT2A inverse 67 Ganciclovir 67 unresectable tumors 67 phase IIb III 67 CA9 SCAN 67 Dalbavancin 67 NEBIDO R 67 PEG interferon 67 Tasigna nilotinib 67 anti CD3 monoclonal 67 Allovectin 7 ® 67 fluoropyrimidine 67 gemcitabine cisplatin 67 Kit CD# positive 67 abacavir lamivudine 67 Aplidin 67 Velcade bortezomib 67 Bendamustine 67 topical ophthalmic 67 GLP toxicology studies 67 serotonin norepinephrine reuptake inhibitor 67 cyclin dependent kinase inhibitor 67 HCD# [002] 67 Initiates Enrollment 67 reversible inhibitor 67 Pertuzumab 67 VitiGam 67 ixabepilone 67 OncoGel 67 Pirfenidone 67 ONCONASE R 67 Onconase 67 Vidaza ® 67 gemcitabine Gemzar 67 DUROS 67 sublingual formulation 67 basiliximab 67 SILENOR 67 indinavir Crixivan 67 cannabinor 67 Phase 2a Clinical Trial 67 Vicinium TM 67 NS5B polymerase 67 OHR/AVR# 67 Prodrug 67 ChronVac C R 67 initiated Phase Ib 67 Prodarsan R 67 RhuDex R 67 NU# direct 67 Pegasys ® 67 fallopian tube cancers 67 human rDNA origin 67 biologic therapy 67 JZP 67 davalintide 67 PROVENGE ® 67 ciprofloxacin hydrochloride 67 Carbamazepine 67 inhaled iloprost 67 5 HT4 67 intranasal delivery 67 Arsenic trioxide 67 Q#IR 67 small molecule glucokinase 67 Bicifadine 67 OvaRex ® MAb 67 biliary tract cancer 67 proprietary transdermal patch 67 Etravirine 67 HQK 67 cisplatin gemcitabine 67 Solazed TM 67 Laquinimod 67 telomerase therapeutic 67 non peptidic protease 67 potent CYP#A# inhibitors 67 CTA# 67 inhaled liposomal ciprofloxacin 67 p# MAP kinase inhibitor 67 Abiraterone acetate 67 Neulasta ® 67 dual endothelin receptor antagonist 67 NB S# strontium malonate 67 acting neuraminidase inhibitor 67 irreversible inhibitor 67 Melphalan 67 GVAX ® 67 MYLOTARG 67 plasma kallikrein inhibitor 67 Phase 2b Trial 67 TOCOSOL 67 refractory NSCLC 67 nalbuphine ER 67 selective kinase inhibitor 67 Cimzia ® certolizumab pegol 67 Boniva ibandronate 67 nucleotide analogue 67 maximally tolerated dose 67 Traficet EN 67 pseudobulbar affect PBA 67 pegylated interferons 67 Vitaxin 67 CD3 monoclonal antibody 67 interferon beta 1b 67 Leukine ® 67 Gleevec resistant 67 insulin aspart 67 Familial Adenomatous Polyposis FAP 67 severe hypercholesterolemia 67 VNP#M 67 Sanofi Aventis Taxotere 67 Mitoxantrone 67 arsenic trioxide injection 67 formerly LymphoStat B 67 humanized therapeutic 67 oral anti arrhythmic 67 Angiocept 67 Everolimus 67 Dyloject TM 67 injectable formulations 67 severe gastroparesis 67 Tofacitinib 67 AS# amonafide L malate 67 Valtropin 67 ZACTIMA 67 Mirapexin 67 Inhalation Solution 67 cediranib 67 recurrent glioblastoma multiforme 67 ATL# [002] 67 Intravenous CP 67 Phase IIa Clinical Trial 67 ribavirin USP 67 circadian cytokine modulator 67 raloxifene Evista 67 DIFICID ™ 67 selective agonist 67 remission induction 67 refractory gout 67 Files Investigational 67 Metastatic Melanoma 67 Posaconazole 67 HuMax TAC 67 tyrosine kinase inhibitor 67 idarubicin 67 Tanespimycin 67 Phase III Clinical Trial 67 SNT MC# 67 ARIKACE ™ 67 epigenetic therapies 67 selective adenosine 67 opioid induced constipation OIC 67 reuptake inhibitor 67 Saizen ® 67 anagrelide 67 Phase IIIb clinical 67 Cancidas 67 Mepact 67 PF # [002] 67 BUPHENYL R sodium phenylbutyrate 67 Sanofi Pasteur Fluzone 67 Oxaliplatin 67 aliskiren amlodipine 67 BCR ABL inhibitors 67 incyclinide 67 Elvitegravir 67 R roscovitine CDK cyclin 67 APTIVUS 67 Cutaneous T 67 Sutent sunitinib 67 sterile lidocaine patch 67 Dabigatran etexilate 67 successfully commercialize Iluvien 67 Major Depressive Disorder MDD 67 pralatrexate injection folate analogue 67 Azedra 67 aleglitazar 67 Junovan TM 67 investigational oral hepatitis C 67 Epothilone D 67 Cytarabine 67 Perforomist ™ Inhalation Solution 67 EOquin 67 trospium chloride 67 CorVue ™ 67 AGHD 67 R#/MEM # 67 JAK2 Inhibitor 67 Solazed 67 CINTREDEKIN BESUDOTOX 67 AVASTIN 67 Soriatane 67 Zavesca r 67 Soliris TM eculizumab 67 P#X# antagonist 67 Humanized Anti 67 Nilotinib 67 Poly ICLC 67 ABILIFY ® 67 mild vasodilator 67 nucleotide analog 67 metastatic sarcomas 67 Opterone R 67 Recombinant Human 67 ularitide 67 immune modulating 67 Phase 2a Trial 67 sevelamer carbonate 67 selective immunoproteasome inhibitor 67 drug ISA# 67 tamoxifen citrate 67 temsirolimus Torisel 67 LHRH antagonists 67 bexarotene 67 salmeterol fluticasone 67 accumulate preferentially 67 Files IND 67 terlipressin 67 sublingual tablets 66 Pruvel 66 ATIR 66 Sumatriptan Succinate 66 nephropathic cystinosis 66 IgG1 monoclonal antibody 66 efaproxiral 66 Janus Kinase 66 lamotrigine Lamictal 66 afamelanotide 66 Troxatyl 66 trastuzumab DM1 66 Saforis 66 Darunavir 66 Atripla combines 66 Fenretinide 66 mGluR2 NAM 66 Combination REOLYSIN R 66 antiplatelet agent 66 cilengitide 66 rALLy 66 NS#/#A protease 66 cutaneous T cell 66 ABLYNX 66 Phase 2a Study 66 Cefazolin 66 PHASE III 66 anticancer agent 66 NPC 1C 66 gonadotrophin releasing hormone GnRH 66 Aerosurf 66 GLP1 agonist 66 Orally Disintegrating Tablets 66 Vincristine 66 MTP inhibitor 66 ELIQUIS 66 secondary hyperparathyroidism 66 eltrombopag 66 urocortin 2 66 Enhanze Technology 66 Successfully Completes Phase 66 Atrasentan 66 Moxifloxacin 66 NMDA antagonist 66 AZILECT ® 66 R#/MEM 66 huC# DM4 66 terfenadine 66 GED aPC 66 class anticancer quinolone 66 LE SN# 66 TNFerade TM 66 Hodgkin lymphoma HL 66 tinidazole 66 YONDELIS R 66 Pathway Inhibitor 66 Onalta 66 antiarrhythmic agent 66 IAP inhibitors 66 regorafenib 66 IND Application 66 Nexavar ® 66 carmustine 66 Alfacell proprietary ribonuclease 66 SomatoKine 66 Ranibizumab 66 Calcium Acetate 66 corticotropin injection 66 Actemra tocilizumab 66 Nipent R 66 Ondansetron Injection USP 66 Zelapar 66 metastatic colorectal 66 HGS ETR2 66 Alzhemed TM 66 Investigational Treatment 66 taxane resistant 66 donepezil Aricept 66 Ranolazine 66 Imatinib mesylate 66 elotuzumab 66 Drug Eluting Stent System 66 triciribine phosphate monohydrate 66 immunosuppressant drug 66 Xelox 66 kidney urologic 66 abacavir Ziagen 66 postoperative ileus POI 66 humanized interleukin 6 66 Bazedoxifene 66 Vernakalant 66 5 HT2C 66 postherpetic neuralgia PHN 66 PPAR gamma agonist 66 peptidic compound 66 Demonstrates Significant 66 thrombolytic agent 66 Solorel TM 66 HuLuc# 66 ALGRX 66 busulfan 66 RhuDex 66 LHRH 66 Copegus ribavirin 66 malignant ascites